Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment
Yoko Tabe, Marina Konopleva
Cancer Drug Resistance (2023) Vol. 6, Iss. 1, pp. 138-150
Open Access | Times Cited: 14

Showing 14 citing articles:

Reprogramming of Fatty Acid Metabolism in Acute Leukemia
Judith Sokei, Joice Kanefsky, Stephen M. Sykes
Journal of Cellular Physiology (2025) Vol. 240, Iss. 1
Closed Access
Acute and Chronic Cardiovascular Adverse Events in Patients with Acute Myeloid Leukemia: A Systematic Review
Konstantinos C. Siaravas, Amalia Ioanna Moula, Ioannis Tzourtzos, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 541-541
Open Access
Upregulation of LSP1 in AML cells enhances AML resistance to sorafenib and promotes apoptosis in CD8+ T cells
Peng Xu, Qiuhui Jiang, Shanlin Fu, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114255-114255
Closed Access
Understanding and Targeting Metabolic Vulnerabilities in Acute Myeloid Leukemia: An Updated Comprehensive Review
Sridevi Addanki, Lana E Kim, Alexandra M. Stevens
Cancers (2025) Vol. 17, Iss. 8, pp. 1355-1355
Open Access
Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia
Jamshid S. Khorashad, Siân Rizzo, Alex Tonks
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Mesenchymal stromal cells, metabolism, and mitochondrial transfer in bone marrow normal and malignant hematopoiesis
Abhishek Kumar Singh, Parash Prasad, José A. Cancelas
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
Lili Feng, Philip Y Zhang, Wenda Gao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
MRD in Acute Leukemias: Lessons Learned from Acute Promyelocytic Leukemia
David Kegyes, Praveena S. Thiagarajan, Gabriel Ghiaur
(2024)
Open Access | Times Cited: 1
Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges
Jan Rataj, Lukáš Górecki, Darina Muthná, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117788-117788
Open Access | Times Cited: 1
Obesity, bone marrow adiposity, and leukemia: Time to act
Vijay Kumar, John H. Stewart
Obesity Reviews (2023) Vol. 25, Iss. 3
Closed Access | Times Cited: 2
The metabolic fuel of paroxysmal nocturnal haemoglobinuria
Luca Guarnera, Valeria Visconte
British Journal of Haematology (2024) Vol. 204, Iss. 6, pp. 2162-2164
Open Access
N6-methyladenosine (m6A) RNA Modification’s Regulatory Role in Acute and Chronic Leukemia
Ziba Majidi, Pariya Mohammadyari, Zahra Kashani Khatib, et al.
Gene Expression (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access
MRD in Acute Leukemias: Lessons Learned from Acute Promyelocytic Leukemia
David Kegyes, Praveena S. Thiagarajan, Gabriel Ghiaur
Cancers (2024) Vol. 16, Iss. 18, pp. 3208-3208
Open Access
Emerging roles for fatty acid oxidation in cancer
Jialin Ma, Shuxian Wang, Pingfeng Zhang, et al.
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101491-101491
Open Access
Page 1

Scroll to top